FMP
AMEX
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.
51.14 USD
-1.1438 (-2.24%)
Valuation Date:
Apr 25, 2024 11:35 AM
Share Price on Valuation Date
$51.14
Stock Beta
0.65
Shares Outstanding
379629